GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IRLAB Therapeutics IRLAB A.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.10

+2.44%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

IRLAB Therapeutics annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 57.5mSEK 94.6mSEK 5.7mSEK 61.1mSEK 207.8m
Operating income−SEK 92.3m−SEK 75.1m−SEK 180.8m−SEK 113.1mSEK 52.6m
Net income−SEK 110.0m−SEK 83.1m−SEK 177.8m−SEK 114.2mSEK 51.8m
Free cash flow−SEK 55.2m−SEK 65.8m−SEK 165.1m−SEK 146.0mSEK 127.9m
Total assetsSEK 138.2mSEK 136.2mSEK 177.1mSEK 323.6mSEK 472.4m
Shareholders' equitySEK 30.7mSEK 32.6mSEK 115.8mSEK 290.8mSEK 399.5m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.